Infectious Diseases
Gain Insights into Infectious Disease with a Robust Cell Analysis Portfolio
Infectious disease research has broad relevance to human health— from revealing mechanism of host-pathogen interactions and vaccine development, to more applied translational research on immune system function and autoimmune disease, researchers are using Agilent Cell Analysis technologies worldwide to advance therapeutic opportunities relating to viral and microbial infection.
Agilent Cell Analysis offers a wide portfolio of products for a complete solution for your infectious disease research.
- Track virus-induced cytopathic effects in real-time for neutralizing antibody research, greatly reduce workload and manual handling of samples with the xCELLigence real-time cell analysis (RTCA) platform
- Seahorse XF technology measures the two major metabolic pathways, glycolysis and mitochondrial respiration, for live cells in real time, providing a critical systems-level view for host-pathogen interaction and innate immune response to infection, and providing insight into potential therapeutic targets.
- Soluble Metabolic Sensors MitoXpress & pH-Xtra provide a high throughput, mix-and-measure, plate reader assessment of mitochondrial function and cell metabolism. Including investigating microbial metabolism, screening for antimicrobial compounds, as well as Anti-parasitic drug screening and drug target discovery.
- Novocyte flow cytometry provides robust, sensitive and automated quantitative assays relevant to infectious disease research such as bacterial cell counting and viability that are compatible with many apoptotic dyes and reagents.
View Agilent Cell Analysis webinars on-demand page to discover applications in cancer research.
For Research Use Only. Not for use in diagnostic procedures.
Videos
